Rouan Sarah Kathryn 4
4 · Viking Therapeutics, Inc. · Filed Feb 8, 2024
Insider Transaction Report
Form 4
Rouan Sarah Kathryn
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-02-08$8.32/sh+25,000$208,000→ 25,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-08−25,000→ 0 totalExercise: $8.32From: 2020-07-01Exp: 2029-07-01→ Common Stock (25,000 underlying) - Sale
Common Stock, par value $0.00001 per share
2024-02-08$28.05/sh−25,000$701,250→ 0 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2023.